Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$420K Sell
4,956
-1,097
-18% -$88.1K 0.03% 433
2026
Q1
$507K Buy
6,053
+103
+2% +$7.76K 0.05% 323
2025
Q4
$399K Sell
5,950
-525
-8% -$33.9K 0.04% 389
2025
Q3
$438K Buy
6,475
+293
+5% +$21.2K 0.04% 378
2025
Q2
$461K Buy
6,182
+764
+14% +$50.9K 0.05% 358
2025
Q1
$341K Sell
5,418
-393
-7% -$24.3K 0.04% 397
2024
Q4
$331K Buy
5,811
+1,127
+24% +$66.6K 0.04% 397
2024
Q3
$275K Buy
+4,684
New +$256K 0.03% 416

Other funds holding CTVA

Norden Group's CTVA Position: Q2 2026 in Review

Norden Group reduced its Corteva (CTVA) stake by 18% in Q2 2026, selling an estimated $88.1K and leaving 4,956 shares worth $420K. The position accounts for 0.03% of the portfolio, ranked #433.

Norden Group first reported a position in CTVA in Q3 2024 and has held it in 8 quarters since. The position peaked at $507K in Q1 2026. 1,487 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • Norden Group held 4,956 shares of Corteva worth $420K as of Q2 2026.
  • Norden Group sold 1,097 Corteva shares in Q2 2026, an estimated $88.1K.
  • Corteva made up 0.03% of Norden Group's portfolio in Q2 2026, its #433 holding.
  • Norden Group first reported a position in Corteva in Q3 2024 and has held it in 8 quarters since.
  • Norden Group's Corteva position peaked at $507K in Q1 2026.
  • 1,487 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Norden Group's 13F filing for Q2 2026, filed 29 Jul 2026.